Diabetes Pro Quarterly - Fall 2020 - 15

Clinical News
Diabetes and COVID-19: Growing
Understanding of the Links
Diabetes Care has published a new collection of articles
examining diabetes and COVID-19 in a special section
of its October issue. In a commentary introducing the
section, Diabetes Care Editor-in-Chief Matthew C. Riddle,
MD, writes that, while we learned a lot from early reports
providing "helpful but necessarily tentative guidance,"
studies reported more recently in Diabetes Care have
tested specific questions about COVID-19 and diabetes,
adding further insights."
These questions include:
* Are people with type 1 diabetes as vulnerable as those with
type 2 diabetes?
* Can increases in risk of complications from diabetes,
including amputation, be attributed to disruptions in care
during lockdown?
* What are the physiologic links between diabetes and
COVID-19, including body composition, as well as social
and economic factors that play a role?
* Does hyperglycemia influence progression to severe
COVID-19 illness? If so, can improving glycemic control
reduce the likelihood of severe illness or improve outcomes?
The articles included in this third Diabetes Care Diabetes
and COVID-19 special section "highlight the rapid progress
in understanding COVID-19 and its relation to diabetes," Dr.
Riddle writes, noting that Diabetes Care continues to "maintain
high standards in selecting articles on this crucial topic."
The current collection is available in the October issue in print
and online at care.diabetesjournals.org/content/43/10.
All three Diabetes and COVID-19 special collections are
freely accessible at care.diabetesjournals.org/collection/
diabetes-and-COVID19.

Effective Basal Insulin Initiation and
Treatment in People With Type 2 Diabetes:
Focus on Mitigating Hypoglycemia in Patients
at Increased Risk
Clinical Diabetes has published a digital program dedicated
to the effective use of basal insulin to treat people with type 2
diabetes. In a short video series, an expert panel moderated
by John Anderson, MD, discusses approaches to optimizing
basal insulin initiation and treatment in people with type 2
diabetes, including in patients most at risk (e.g., those with
renal impairment and older adults), with a focus on reaching
A1C goals while mitigating the risk of hypoglycemia.
Many people with type 2 diabetes are treated with insulin
with the goal of achieving a specific A1C target. The panel
discusses how considerations for the management of
hypoglycemia are important in treating these patients.
When basal insulin analogs are used appropriately, the
risk of hypoglycemia can be reduced while still achieving
glycemic goals.
Dr. Anderson is joined by Paresh Dandona, MD, PhD; Geralyn
R. Spollett, MSN, ANP, CDE; and Scott Urquhart, PA-C,
MPAS. The videos and an executive summary of the panel's
recommendation are available on the Clinical Diabetes
website at clinical.diabetesjournals.org/content/basalinsulin-videos. Financial support for this digital publication
was provided by Sanofi.

Did You Know?
DiabetesPro SmartBrief is a free daily
diabetes briefing on what is going on in the
clinical diabetes community. Sign up today for
daily emails: smartbrief.com/diabetespro

Diabetes Core Update: Special Podcast Series Available
Diabetes Core Update is a monthly audio podcast devoted to presenting and discussing the
latest clinically relevant articles from ADA's four scholarly journals.
In addition to its regularly released monthly audio digest format, Diabetes Core Update has
recently released several special podcast series related to topics of interest for the diabetes
clinical care community. In the latest three-part special series, hosts Neil Skolnik, MD, and
John Russell, MD, discuss the dramatic cardiovascular and renal outcomes results of clinical
trials involving sodium-glucose cotransporter 2 inhibition in type 2 diabetes. Also available
are discussions involving the impact of influenza on people with diabetes and the importance
of influenza vaccination for people with diabetes and a multi-part series on disrupting therapeutic inertia in diabetes
management. These projects were made possible through unrestricted educational grants from AstraZenca, Sanofi
Pasteur, and Sanofi, respectively.
Diabetes Core Update podcasts are free and can be accessed through Apple Podcasts and Google Play. For more
information or to listen or download on your computer or mobile device, visit diabetesjournals.org/content/diabetescore-update-podcasts.

professional.diabetes.org

Diabetes Pro Quarterly - Fall 2020

Table of Contents for the Digital Edition of Diabetes Pro Quarterly - Fall 2020